Pallas Capital Advisors LLC acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 13,912 shares of the medical instruments supplier's stock, valued at approximately $264,000.
Several other large investors have also recently bought and sold shares of XRAY. First Eagle Investment Management LLC increased its stake in DENTSPLY SIRONA by 33.6% in the 2nd quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier's stock valued at $325,571,000 after purchasing an additional 3,283,965 shares in the last quarter. FMR LLC raised its stake in shares of DENTSPLY SIRONA by 5.1% during the 3rd quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier's stock worth $245,076,000 after buying an additional 436,031 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of DENTSPLY SIRONA by 42.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier's stock worth $110,118,000 after buying an additional 1,308,411 shares during the last quarter. Armistice Capital LLC grew its stake in DENTSPLY SIRONA by 31.5% in the 2nd quarter. Armistice Capital LLC now owns 2,298,000 shares of the medical instruments supplier's stock valued at $57,243,000 after acquiring an additional 550,945 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in DENTSPLY SIRONA by 50.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier's stock valued at $55,900,000 after acquiring an additional 692,100 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company's stock.
Analysts Set New Price Targets
XRAY has been the topic of several research reports. Mizuho started coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, December 4th. They issued a "neutral" rating and a $21.00 price target on the stock. StockNews.com cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Tuesday, November 19th. Morgan Stanley cut their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a report on Tuesday, December 17th. Evercore ISI reaffirmed an "in-line" rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Finally, UBS Group dropped their price objective on DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating for the company in a research report on Tuesday, December 3rd. Nine investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat, DENTSPLY SIRONA has a consensus rating of "Hold" and a consensus price target of $27.27.
Get Our Latest Report on XRAY
DENTSPLY SIRONA Trading Up 1.1 %
Shares of NASDAQ XRAY traded up $0.20 on Thursday, reaching $18.44. 2,524,368 shares of the company traded hands, compared to its average volume of 2,675,457. The stock has a market capitalization of $3.67 billion, a PE ratio of -8.91, a P/E/G ratio of 1.69 and a beta of 0.96. DENTSPLY SIRONA Inc. has a fifty-two week low of $17.21 and a fifty-two week high of $36.63. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a 50 day moving average of $18.87 and a 200 day moving average of $22.91.
DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA's revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.49 earnings per share. On average, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.
DENTSPLY SIRONA Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 3.47%. The ex-dividend date was Friday, December 27th. DENTSPLY SIRONA's payout ratio is currently -30.92%.
About DENTSPLY SIRONA
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading
Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.